Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1139 of 1,261
  1. US 6849605

    Inhibitors of serine protease activity, methods and compositions for treatment of viral infections

    The Regents of the University of Technology Office of Technology Transfer Β· Granted Feb 1, 2005 Β· Expires Jan 27, 2025

    expired
  2. US 6849429

    Viral pseudo-capsids including assembly agonists and antagonists

    The Board of Regents of the University of Texas System Β· Granted Feb 1, 2005 Β· Expires Jan 27, 2025

    expired
  3. US 6849417

    Mammalian selenoprotein differentially expressed in tumor cells

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Feb 1, 2005 Β· Expires Jan 27, 2025

    expired
  4. US 6849621

    Piperidine compounds

    Pharmacopeia Drug Discovery, Inc. Β· Granted Feb 1, 2005 Β· Expires Jan 27, 2025

    expired
  5. US 6849602

    Compositions for alleviating neuropathic pain with prosaposin receptor agonists

    The Regents of the University of California Β· Granted Feb 1, 2005 Β· Expires Jan 27, 2025

    expired
  6. US 6849112

    Inorganic particles as a dental material and a method of producing the same

    CATALYSTS & CHEMICALS INDUSTRIES CO., LTD. Β· Granted Feb 1, 2005 Β· Expires Jan 27, 2025

    expired
  7. US 6849120

    Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and methods of preparing the crystalline forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Feb 1, 2005 Β· Expires Jan 27, 2025

    expired
  8. US 6848211

    Cultivated agarwood

    Regents of the University of Minnesota Β· Granted Feb 1, 2005 Β· Expires Jan 27, 2025

    expired
  9. US 6849630

    Cyclized amino acid derivatives

    Vertex Pharmaceuticals Incorporated Β· Granted Feb 1, 2005 Β· Expires Jan 27, 2025

    expired
  10. US 6849267

    Compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated Β· Granted Feb 1, 2005 Β· Expires Jan 27, 2025

    expired
  11. US 6846928

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  12. US 6846799

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  13. US 6846829

    N-heterocyclic derivatives as NOS inhibitors

    Pharmacopeia Drug Discovery, Inc. Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  14. US 6846809

    PEI: DNA vector formulations for in vitro and in vivo gene delivery

    The Board of Regents of the University of Texas System Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  15. US 6846908

    DCR-5 bone affecting ligand

    REGENERON PHARMACEUTICALS, INC. Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  16. US 6846817

    Nicotine receptor ligands

    Regents of the University of Minnesota Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  17. US 6846840

    Cytotoxic N-unsubstituted indoles and cyclopent(B)indoles and method of making and using same

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  18. US 6846807

    Colorectal neoplasia prophylaxis

    The Board of Regents of the University of Texas System Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  19. US 6846652

    Viral vectors having enhanced effectiveness with reduced virulence

    THE ARIZONA BOARD OF REGENTS Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  20. US 6846644

    Oncoprotein protein kinase

    The Regents of the University of California Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  21. US 6846484

    DTAT fusion toxin

    Regents of the University of Minnesota Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  22. US 6846914

    Tie-2 ligand-3

    REGENERON PHARMACEUTICALS, INC. Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  23. US 6846915

    Hydroxypyridonate and hydroxypyrimidinone chelating agents

    The Regents of the University of California Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired
  24. US 6846480

    Cleaning article containing hydrophilic polymers

    ReGenesis Group Β· Granted Jan 25, 2005 Β· Expires Jan 20, 2025

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.